CRScube Expands Global Presence with New Office in the UK
LONDON, Aug. 1, 2024 /PRNewswire/ -- CRScube Inc. (CEO Stanley Kim), a leading clinical trial software solutions company, proudly announces the opening of its new office in London, marking a significant milestone in its global expansion strategy. Building on a foundation of unparalleled success in Asia, this strategic move underscores the company's commitment to bringing innovative solutions to...
Angel Yeast Brings Together Innovative Consortium to Build Industrial Park for Synthetic Biology Development
SHANGHAI, Aug. 1, 2024 /PRNewswire/ -- Angel Yeast (SH600298), a global leader in yeast manufacturing, is spearheading an initiative that unites universities and enterprises to form an innovative consortium dedicated to advancing synthetic biology technology. This initiative also accelerates the construction of the Xiaoting Synthetic Biology Industrial Park in Yichang, Hubei Province. The...
1,000+ Medical Device Manufacturing Leaders Gather at Medtec 2024
Experts Deliver Key Insights into Industry Trends SHANGHAI, Aug. 1, 2024 /PRNewswire/ -- The Government Work Report releases in early 2024 emphasized the need to "explore new avenues in life sciences." As a key area for developing new productivity, the medical device industry encompasses both the emerging high-end manufacturing sector and the future-focused healthcare sector. Medtec, a major exhibition for...
Novel Non-Covalent Hits Against GPX4 Identified Using the RiDYMO® Reinforced Dynamics Platform of DP Technology
Research on ferroptosis is gaining momentum, but the development of small molecule inhibitors faces numerous challenges BEIJING, Aug. 1, 2024 /PRNewswire/ -- Glutathione peroxidase 4 (GPX4) is recognized as a critical regulator of ferroptosis, playing a significant role in lipid and amino acid metabolism, as well as influencing cellular aging, oncogenesis, and cell death . Targeting GPX4-mediated ferroptosis presents...
The Director General of Pharmaceuticals and Medical Devices Visits Fapon in Indonesia
JAKARTA, Indonesia, Aug. 1, 2024 /PRNewswire/ -- The Ministry of Health of the Republic of Indonesia, represented by the Director General of Pharmaceuticals and Medical Devices (Dirjen Falmakes), Dr. Dra. Lucia Rizka Andalucia, along with the Director of Medical Device Production and Distribution Mr. Dede Mulyadi, and the Director of Medical Device...
Innovent Announces the NDA of Mazdutide for Type 2 Diabetes has been Accepted by the NMPA of China
SAN FRANCISCO, U.S. and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that the second New Drug Application (NDA) of mazdutide, a glucagon-like peptide-1 receptor (GLP-1R) and glucagon...
Biosyngen Partners with Singapore’s Agency for Science, Technology and Research (A*STAR) to Advance Autoimmune Therapy
GUANGZHOU, China, Aug. 1, 2024 /PRNewswire/ -- Biosyngen has announced a strategic collaboration with Singapore's Agency for Science, Technology and Research (A*STAR) to enhance autoimmune therapy. The partnership was signed during the 14th Meeting of the Singapore-Guangdong Collaboration Council, held at China-Singapore Guangzhou Knowledge City (CSGKC) on July 31, 2024. ...
MGI Tech Partners with UNALM and Inca Tops to Enhance Alpaca Fiber and Strengthen Peru’s Textile Industry
A genetic sequencing project involving 1,500 alpacas from Puno aims to refine the quality and fineness of their fiber. The adoption of genomics in the alpaca industry offers many advantages, such as enhancing the quality of alpaca fiber and promoting the growth of thousands of producers in the highlands. LIMA,...
WuXi Biologics’ Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics
WUXI and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that four manufacturing facilities and Suzhou Biosafety Testing Center in China have received Good Manufacturing Practice (GMP) certificates from the European Medicines Agency (EMA), demonstrating the company's commitment to meeting rigorous international industry quality standards...
Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced a partnership with Gore Range Capital LLC ("Gore Range Capital") (Dallas, TX, USA) for establishment of a joint venture, Sagesse...
